Frailty score may reveal hidden risks for young septic shock patients

NCT ID NCT05928767

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether frailty—measured by a simple scale—can predict death in adults aged 18 to 65 admitted to intensive care for septic shock. Researchers will track 200 patients to see if those who are frail have a higher risk of dying within 28 days, even after accounting for other factors. The goal is to help doctors and families make better decisions about care intensity and expectations.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help doctors better predict outcomes for younger septic shock patients and tailor care intensity based on frailty.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly change patient care. Results may not apply to all ICU settings or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FRAILTY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CH Boulogne sur Mer

    RECRUITING

    Boulogne-sur-Mer, 62321, France

    Contact

  • CH de Lens

    RECRUITING

    Lens, France

    Contact

  • CHU Lille

    RECRUITING

    Lille, 59037, France

    Contact

  • CHU de Dijon

    RECRUITING

    Dijon, 21079, France

    Contact

  • Ch Germon Et Gauthier

    RECRUITING

    Béthune, 62408, France

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.